281 related articles for article (PubMed ID: 12065605)
21. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
Alexander SP; Curtis AR; Kendall DA; Hill SJ
Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
[TBL] [Abstract][Full Text] [Related]
22. Histamine-and isoprenaline-evoked stimulation of cAMP formation in chick cerebral cortex.
Nowak JZ; Zawilska JB
Pol J Pharmacol; 1995; 47(6):541-4. PubMed ID: 8868378
[TBL] [Abstract][Full Text] [Related]
23. Desensitization of histamine H1 receptor-mediated inositol phosphate accumulation in guinea pig cerebral cortex slices.
Bristow DR; Banford PC; Bajusz I; Vedat A; Young JM
Br J Pharmacol; 1993 Sep; 110(1):269-74. PubMed ID: 8106103
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats.
Blandina P; Giorgetti M; Bartolini L; Cecchi M; Timmerman H; Leurs R; Pepeu G; Giovannini MG
Br J Pharmacol; 1996 Dec; 119(8):1656-64. PubMed ID: 8982515
[TBL] [Abstract][Full Text] [Related]
25. Binding of 4(5)-[2-(4-azido-2-nitroanilino)ethyl]imidazole to histamine receptors in guinea pig cerebral cortical membranes.
Horstemeyer DL; Ice KS; Hogaboom GK; O'donnell JP; Smith DJ; Fedan JS
Proc Soc Exp Biol Med; 1986 Apr; 181(4):486-91. PubMed ID: 3952080
[TBL] [Abstract][Full Text] [Related]
26. Specific binding of 3H-tiotidine to histamine H2 receptors in guinea pig cerebral cortex.
Gajtkowski GA; Norris DB; Rising TJ; Wood TP
Nature; 1983 Jul 7-13; 304(5921):65-7. PubMed ID: 6135157
[TBL] [Abstract][Full Text] [Related]
27. Histamine H1 receptors in rat dorsal raphe nucleus: pharmacological characterisation and linking to increased neuronal activity.
Bárbara A; Aceves J; Arias-Montaño JA
Brain Res; 2002 Nov; 954(2):247-55. PubMed ID: 12414108
[TBL] [Abstract][Full Text] [Related]
28. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
29. H3 receptor-mediated inhibition of intestinal acetylcholine release: pharmacological characterization of signal transduction pathways.
Blandizzi C; Colucci R; Tognetti M; De Paolis B; Del Tacca M
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):193-202. PubMed ID: 11219402
[TBL] [Abstract][Full Text] [Related]
30. H2 receptor-mediated facilitation and H3 receptor-mediated inhibition of noradrenaline release in the guinea-pig brain.
Timm J; Marr I; Werthwein S; Elz S; Schunack W; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):232-9. PubMed ID: 9550293
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
[TBL] [Abstract][Full Text] [Related]
32. Histamine H(2) receptors mediate the inhibitory effect of histamine on human eosinophil degranulation.
Ezeamuzie CI; Philips E
Br J Pharmacol; 2000 Oct; 131(3):482-8. PubMed ID: 11015298
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of cyclic adenosine 3', 5'-monophosphate in chick cerebral hemisphere slices: effects of H1 and H2 histaminergic agonists and antagonists.
Nahorski SR; Rogers KJ; Smith BM
Brain Res; 1977 May; 126(2):387-90. PubMed ID: 16684
[No Abstract] [Full Text] [Related]
34. In vitro histamine H2-antagonist activity of the novel compound HUK 978.
Coombes JD; Norris DB; Rising TJ; Ross BC; Steward A
Life Sci; 1985 Nov; 37(18):1711-8. PubMed ID: 3840559
[TBL] [Abstract][Full Text] [Related]
35. Histamine protects against NMDA-induced necrosis in cultured cortical neurons through H receptor/cyclic AMP/protein kinase A and H receptor/GABA release pathways.
Dai H; Zhang Z; Zhu Y; Shen Y; Hu W; Huang Y; Luo J; Timmerman H; Leurs R; Chen Z
J Neurochem; 2006 Mar; 96(5):1390-400. PubMed ID: 16478529
[TBL] [Abstract][Full Text] [Related]
36. Long-term increase of hippocampal excitability by histamine and cyclic AMP.
Selbach O; Brown RE; Haas HL
Neuropharmacology; 1997; 36(11-12):1539-48. PubMed ID: 9517424
[TBL] [Abstract][Full Text] [Related]
37. Selective ligands as tools to study histamine receptors.
van der Goot H; Timmerman H
Eur J Med Chem; 2000 Jan; 35(1):5-20. PubMed ID: 10733599
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of action of H2-antagonists on histamine- or dimaprit-stimulated H2-receptors of spontaneously beating guinea-pig atrium.
Krielaart MJ; Veenstra DM; van Buuren KJ
Agents Actions; 1990 Aug; 31(1-2):23-35. PubMed ID: 1704683
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the binding of the first selective radiolabelled histamine H3-receptor antagonist, [125I]-iodophenpropit, to rat brain.
Jansen FP; Wu TS; Voss HP; Steinbusch HW; Vollinga RC; Rademaker B; Bast A; Timmerman H
Br J Pharmacol; 1994 Oct; 113(2):355-62. PubMed ID: 7834183
[TBL] [Abstract][Full Text] [Related]
40. Involvement of presynaptic histamine H3 receptors in the modulation of somatostatin binding and its effects on adenylyl cyclase activity in the rat frontoparietal cortex.
Puebla L; Arilla E
J Neurochem; 1996 Mar; 66(3):1051-9. PubMed ID: 8769866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
